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Objective: Analysis of hemodynamic characteristics of patients with uremic
hypertension.0310
Table 1 Comparisons of age and blood pressure in uremic group, hy-
pertension group and control group (x  s).
Groups Case Age
Year
SBP
mmHg
DBP
mmHg
Uremic 104 59.114.8 16619 8917
Hypertension 76 61.09.6 16611A 916A
Control 85 59.317.1 11115: 6812:
F value 0.019 159.499 46.851
P value 0.889 0.000 0.000
+Uremic group compared with hypertension group, P<0.01; ++Uremic
group compared with hypertension group, P<0.05; AHypertension
group compared with control group, P<0.01AAHypertension group
compared with control group, P<0.05; :Uremic group compared with
control group, P<0.01; ::Uremic group compared with control group,
P<0.05. The following tables are the same.
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Table 2 The comparisons of volume overload in the three groups (x  s).
Groups No. LSV
mL
ECV
mL
Uremic 104 217106+ 43311252+
Hypertension 76 17382A 39801201A
Control 85 7541: 2477583:
F value 134.991 136.528
P value 0.000 0.000
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Table 3 Comparison of myocardial contractility in the three groups (x  s).
Groups No. EP
mmHg
LDP
mmHg
Uremia 104 18924+ 15.95.7+
Hypertension 76 17922A 13.24.0A
Control 85 11518: 10.93.2:
F value 344.762 39.400
P value 0.000 0.000
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Table 4 Comparison of peripheral resistance in the three groups (x  s).
Groups No. OM
Ncm2
MAM
Ncm2
Uremia 104 11.53.9+ 16.54.7+
Hypertensive 76 9.61.8 14.63.1A
Control 85 9.73.7: 11.14.0:
T value 14.956 80.568
P value 0.040 0.000
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Table 5 Comparisons of neural regulation and cardiac work efficiency in the
Groups No. LVW
Js-1
LME
Uremia 104 4.591.78+ 0.0970.047+
Hypertension 76 3.771.39A 0.1240.048A
Control 85 1.690.78: 0.1740.067:
T value 193.675 94.602
P value 0.000 0.000Methods: A non-invasive hemodynamics detector was used to analyze
volume overload, peripheral resistance, myocardial contractility, and
neural regulation difference in patients with hypertension, uremic hy-
pertension and normotensive persons (control group). Additional Logistic
regression analysis was carried out for risk factors that impacts uremic
hypertension.
Results: (1) 14.5% of high resistance hypertension and 5.3% of high vol-
ume hypertension in patients with hypertension; 5.8% of high resistance
hypertension and 19.2% of high volume hypertension in patients with
uremic hypertension; c2Z3.890, 7.821, PZ 0.049, 0.005. (2) The vol-
ume overload of patients with uremic hypertension is much higher
than it in patients with hypertension and control group. (3) The periph-
eral resistance of patients with uremic hypertension is much lower than
it in patients with hypertension and control group. (4) The vagal tone
and myocardial contractile efficiency of patients with uremic hyperten-
sion are much lower than it in patients with hypertension and control
group.
Conclusion: Patients with uremic hypertension are performed of volume
overload increasing, peripheral resistance, vagal tone and myocardial
contractile efficiency decreasing. Also, rise of CO and decline of VFC
are main risk factors of uremic hypertension. Blindly expansion of blood
vessels is difficult to reach the antihypertensive effect, while clearance
of water sodium retention, reduction of sympathetic nerve tension and
improvement of cardiac function would do much good for controlling of
hypertension.SV
mL
CO
L$min-1
LDV
mL
+ 16456+ 14.14.7+ 381160+
13746A 11.13.1A 310124A
8928: 7.83.3: 16466:
123.068 123.729 136.493
0.000 0.000 0.000
MIC EF LSP
mmHg
2.490.29+ 0.4410.059++ 11516
2.660.30 0.4580.041A 1166A
2.640.67: 0.5530.068: 8312:
7.379 165.698 104.572
0.007 0.000 0.000
AOM
Ncm2
MVO
s-1
SSR
gcm-4s-1
7.62.7++ 89.148.1+ 988282+
8.41.9A 66.832.5A 1204242A
4.81.7: 25.914.7: 1085285:
70.134 143.861 33.358
0.000 0.000 0.000
three groups (x  s).
MIM
Gcm-4
VFC SFC
609283+ 0.0130.005++ 0.380.10+
737269A 0.0160.005A 0.420.06A
871289: 0.0280.012: 0.330.11:
40.698 174.579 13.688
0.000 0.000 0.000
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Table 6 Comparisons of hemodynamics of uremic hypertensive group and hypertensive group (x  s).
Groups High volume Hyperkinetic High volume combined
with hyperkinesis
High volume combined hyperkinesis
and high resistance
High resistance
No. % No. % No. % No. % No. %
Uremia 20 19.2 3 2.9 45 43.3 14 13.5 7 5.8
Hypertension 4 5.3 1 1.3 25 32.9 25 32.9 11 14.5
c2 7.821 0.497 1.989 9.771 3.890
P value 0.005 0.481 0.158 0.002 0.049
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Table 7 Logistic regression analysis of factors leading to uremic hypertension.
Factors c2 P value OR 95% confidence interval of OR
Age 14.804 0.000 1.063 0.931～1.195
CO 26.303 0.000 3.436 3.361～3.511
EF 10.658 0.001 1.409 1.225～1.593
LSV 4.904 0.027 1.012 0.612～1.412
VFC 11.644 0.001 3.235 3.067～3.403
CVP 21.473 0.000 1.306 1.215～1.397
MIM 14.232 0.000 1.005 0.867～1.143
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F-actin Rearrangement is Involved in Decreased Cell-surface Expression
of Slo1 and BKCa Channel Inhibition Caused by Hypoxia in a Conditionally
Immortalized Human Podocyte Cell Line
Rui Zhang
Harbin Medical University, Harbin, Heilongjiang, China
There is much evidence to show that hypoxia and ischemia compromise
the structure and function of podocytes. Chronic hypoxia involved in
nephrosclerosis is an alternative mechanism for the pathogenesis of
rapidly progressive glomerulonephritis. Large-conductance Ca2+ activated
K+ channels (BKCa channels) encoded by the Slo1 gene are characterized
as mechanosensitive and oxygen-sensitive channels in podocytes. Howev-
er, whether BKCa channels are involved in the podocyte response to
chronic hypoxia and the possible underlying mechanisms remain unclear.
A conditionally immortalized human podocyte cell line transfected with
the temperature-sensitive SV40 gene construct was cultured and differ-
entiated. We used the patch clamp technique to show that the exposure
of human podocytes to 2% O2 for 24 hours causes a significant reduction in
BKCa channel currents. FITC-phalloidin staining display that hypoxia and
cytochalasin D cause F-actin rearrangement and depolymerization in
podocytes. Furthermore, cell-surface biotinylation assays indicate a
marked decrease in surface expression of Slo1 in anoxia. However, the to-
tal amount of Slo1 expression in whole cell has no significant variation af-
ter hypoxic treatment. Thus, we conclude that chronic hypoxia inhibits
podocytes BKCa channel currents by F-actin rearrangement and reduced
Slo1 expression on cell membrane. These findings provide new insight
into the mechanism underlying the cellular responses of podocytes to
hypoxia.http://dx.doi.org/10.1016/j.hkjn.2015.08.083
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